302 related articles for article (PubMed ID: 16624886)
1. Specific rescue of cystic fibrosis transmembrane conductance regulator processing mutants using pharmacological chaperones.
Wang Y; Bartlett MC; Loo TW; Clarke DM
Mol Pharmacol; 2006 Jul; 70(1):297-302. PubMed ID: 16624886
[TBL] [Abstract][Full Text] [Related]
2. Rescue of DeltaF508 and other misprocessed CFTR mutants by a novel quinazoline compound.
Loo TW; Bartlett MC; Clarke DM
Mol Pharm; 2005; 2(5):407-13. PubMed ID: 16196493
[TBL] [Abstract][Full Text] [Related]
3. Rescuing cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by transcomplementation.
Cormet-Boyaka E; Jablonsky M; Naren AP; Jackson PL; Muccio DD; Kirk KL
Proc Natl Acad Sci U S A; 2004 May; 101(21):8221-6. PubMed ID: 15141088
[TBL] [Abstract][Full Text] [Related]
4. Modulating the folding of P-glycoprotein and cystic fibrosis transmembrane conductance regulator truncation mutants with pharmacological chaperones.
Wang Y; Loo TW; Bartlett MC; Clarke DM
Mol Pharmacol; 2007 Mar; 71(3):751-8. PubMed ID: 17132688
[TBL] [Abstract][Full Text] [Related]
5. Corrector-mediated rescue of misprocessed CFTR mutants can be reduced by the P-glycoprotein drug pump.
Loo TW; Bartlett MC; Shi L; Clarke DM
Biochem Pharmacol; 2012 Feb; 83(3):345-54. PubMed ID: 22138447
[TBL] [Abstract][Full Text] [Related]
6. Direct interaction of a small-molecule modulator with G551D-CFTR, a cystic fibrosis-causing mutation associated with severe disease.
Pasyk S; Li C; Ramjeesingh M; Bear CE
Biochem J; 2009 Feb; 418(1):185-90. PubMed ID: 18945216
[TBL] [Abstract][Full Text] [Related]
7. A small-molecule modulator interacts directly with deltaPhe508-CFTR to modify its ATPase activity and conformational stability.
Wellhauser L; Kim Chiaw P; Pasyk S; Li C; Ramjeesingh M; Bear CE
Mol Pharmacol; 2009 Jun; 75(6):1430-8. PubMed ID: 19339490
[TBL] [Abstract][Full Text] [Related]
8. Dynasore inhibits removal of wild-type and DeltaF508 cystic fibrosis transmembrane conductance regulator (CFTR) from the plasma membrane.
Young A; Gentzsch M; Abban CY; Jia Y; Meneses PI; Bridges RJ; Bradbury NA
Biochem J; 2009 Jul; 421(3):377-85. PubMed ID: 19442237
[TBL] [Abstract][Full Text] [Related]
9. Identification of natural coumarin compounds that rescue defective DeltaF508-CFTR chloride channel gating.
Xu LN; Na WL; Liu X; Hou SG; Lin S; Yang H; Ma TH
Clin Exp Pharmacol Physiol; 2008 Aug; 35(8):878-83. PubMed ID: 18430055
[TBL] [Abstract][Full Text] [Related]
10. Correctors promote folding of the CFTR in the endoplasmic reticulum.
Loo TW; Bartlett MC; Clarke DM
Biochem J; 2008 Jul; 413(1):29-36. PubMed ID: 18361776
[TBL] [Abstract][Full Text] [Related]
11. Rescue of DeltaF508-CFTR (cystic fibrosis transmembrane conductance regulator) by curcumin: involvement of the keratin 18 network.
Lipecka J; Norez C; Bensalem N; Baudouin-Legros M; Planelles G; Becq F; Edelman A; Davezac N
J Pharmacol Exp Ther; 2006 May; 317(2):500-5. PubMed ID: 16424149
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.
Kerem E
Pediatr Pulmonol; 2005 Sep; 40(3):183-96. PubMed ID: 15880796
[TBL] [Abstract][Full Text] [Related]
13. Additive effect of multiple pharmacological chaperones on maturation of CFTR processing mutants.
Wang Y; Loo TW; Bartlett MC; Clarke DM
Biochem J; 2007 Sep; 406(2):257-63. PubMed ID: 17535157
[TBL] [Abstract][Full Text] [Related]
14. Surface expression of the cystic fibrosis transmembrane conductance regulator mutant DeltaF508 is markedly upregulated by combination treatment with sodium butyrate and low temperature.
Heda GD; Marino CR
Biochem Biophys Res Commun; 2000 May; 271(3):659-64. PubMed ID: 10814518
[TBL] [Abstract][Full Text] [Related]
15. The chemical chaperone CFcor-325 repairs folding defects in the transmembrane domains of CFTR-processing mutants.
Loo TW; Bartlett MC; Wang Y; Clarke DM
Biochem J; 2006 May; 395(3):537-42. PubMed ID: 16417523
[TBL] [Abstract][Full Text] [Related]
16. The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR.
Du K; Sharma M; Lukacs GL
Nat Struct Mol Biol; 2005 Jan; 12(1):17-25. PubMed ID: 15619635
[TBL] [Abstract][Full Text] [Related]
17. A chemical corrector modifies the channel function of F508del-CFTR.
Kim Chiaw P; Wellhauser L; Huan LJ; Ramjeesingh M; Bear CE
Mol Pharmacol; 2010 Sep; 78(3):411-8. PubMed ID: 20501743
[TBL] [Abstract][Full Text] [Related]
18. Base treatment corrects defects due to misfolding of mutant cystic fibrosis transmembrane conductance regulator.
Namkung W; Kim KH; Lee MG
Gastroenterology; 2005 Dec; 129(6):1979-90. PubMed ID: 16344066
[TBL] [Abstract][Full Text] [Related]
19. Correction of the Delta phe508 cystic fibrosis transmembrane conductance regulator trafficking defect by the bioavailable compound glafenine.
Robert R; Carlile GW; Liao J; Balghi H; Lesimple P; Liu N; Kus B; Rotin D; Wilke M; de Jonge HR; Scholte BJ; Thomas DY; Hanrahan JW
Mol Pharmacol; 2010 Jun; 77(6):922-30. PubMed ID: 20200141
[TBL] [Abstract][Full Text] [Related]
20. Repair of CFTR folding defects with correctors that function as pharmacological chaperones.
Loo TW; Clarke DM
Methods Mol Biol; 2011; 741():23-37. PubMed ID: 21594776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
